Optimized 4-(4-Phenylbutoxy)Benzoic Acid Synthesis Route
Procurement managers and process chemists frequently face significant bottlenecks when sourcing critical intermediates like 4-(4-Phenylbutoxy)benzoic Acid. Inconsistent batch quality, undocumented impurities, and supply chain volatility often delay R&D timelines and compromise final API stability.
Technical Specifications and Analytical Methods
At NINGBO INNO PHARMCHEM CO.,LTD., we ensure every lot meets rigorous pharmaceutical standards. Our manufacturing process utilizes an optimized synthesis route to minimize byproducts and maximize yield. Below are the key technical parameters for our C17H18O3 intermediate.
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 30131-16-9 | Verification |
| Purity (HPLC) | ≥ 99.0% | Area Normalization |
| Related Substances | ≤ 0.5% | HPLC/GC |
| Residual Solvents | Meets ICH Q3C | Headpace GC |
| Packaging | 25kg/Drum | Visual Inspection |
Troubleshooting Common Impurities and Yield Issues
Achieving consistent pharmaceutical grade quality requires precise control over reaction conditions. Common challenges in the production of this organic synthesis building block include ether linkage stability and ester hydrolysis efficiency.
Residual Starting Materials
Incomplete conversion during the alkylation step can leave behind phenolic precursors. Our advanced purification protocols ensure these are reduced to trace levels, guaranteeing the industrial purity required for downstream coupling reactions.
Ether Linkage Stability
Thermal stress during the synthesis route can sometimes degrade the ether bond. We maintain strict temperature controls during reflux to prevent cleavage, ensuring the structural integrity of the 4-(4-Phenylbutoxy)benzoic Acid molecule.
Hydrolysis Efficiency
Final acid formation depends on complete ester hydrolysis. Inadequate reaction time or pH control can result in mixed ester-acid profiles. Our quality assurance team verifies complete conversion before release.
Factory-Direct Bulk Pricing Advantages and Supply Chain Stability
As a global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. offers competitive bulk pricing by eliminating intermediary markups. We understand that executives require reliable quality assurance and predictable lead times. Our vertically integrated supply chain mitigates risks associated with raw material shortages, ensuring a steady flow of this vital Ranlukast precursor to your production facility.
Partnering with us provides access to comprehensive technical support and transparent documentation, including full COA verification for every shipment.
To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.